Antihelminthics (Anthelmintics)
Infection with parasitic worms (helminthiasis) is a global problem with
more than 2 billion people estimated to be affected, though tropical countries
demonstrate the maximum prevalence. Common worms encountered include nematodes
(round worms), trematodes (flukes), and cestodes (tapeworms).
Hookworms, threadworms, whipworms,
and guineaworms are also common culprits in India. In some parts of the country
filariasis (due to the nematode Wuchereria
bancrofti), echino-coccosis or hydatid disease (due to the tapeworm Echinococcusgranulosis), and
cysticercosis (due to the larval form of thetapeworm Cysticercus) are occasionally reported.
The following discussion is centred
around the common antihelminthic drugs available in India.
These
are broad -spectrum antihelminthic agents, the most popular of which include
albendazole, cambendazole, meben-dazole, and thiobendazole.
·
Benzimidazoles are effective in the treatment of cutaneous
larva migrans (creeping eruption), strongyloidiasis (threadworm infestation),
hydatid disease, and infestation due to Enterobius
(pinworm), Ancylostoma and Necator (hookworms), Ascaris (roundworm), Trichuris (whipworm) and Taenia solium (tapeworm).
·
Mebendazole has also been used as a fungicide for
controlling spoilage in citrus fruits and Dutch Elm disease. Thiabendazole has
also been used as a fungicidal food preservative.
·
Common side effects include nausea,
vomiting, and vertigo, while ocasionally there may be diarrhoea, headache,
rash, fever, haematuria, and intrahepatic cholestasis. Elevated SGOT, SGPT,
alkaline phosphatase, and BUN have been reported during therapeutic treatment
with mebenda-zole. Colour vision disturbances and tinnitus have been reported
during therapeutic use of thiabendazole. Sicca complex occurs rarely during
thiabendazole therapy; symptoms include reduced tear production and dry mouth.
Neutropenia and leukopenia are rare side effects with high-dose therapy. Mebendazole
and albendazole are less toxic than thiobendazole.
·
Animal experiments suggest that
these drugs are teratogenic and hence should not be administered to pregnant
women.
·
Symptomatic and supportive measures.
·
Activated charcoal/stomach wash may
be helpful in the early stages of an overdose.
·
Hepatic injury generally responds to
supportive care.
·
Monitor for fluid and electrolyte
replacement.
It is a piperazine derivative and
remains the drug of choice for filariasis and tropical pulmonary eosinophilia,
more than 50 years after it was introduced into therapeutics.
Diethylcarbamazine is also used in the treatment of loiasis,* onchocerciasis,
and ascariasis.
Absorption is rapid after oral
administration and toxic effects are uncommon with usual therapeutic doses.
Peak plasma concentrations are reached in 1 to 2 hours, followed by a rapid
decline, then a secondary rise 3 to 6 hours after dosing. The drug does not
distribute in the fat and consequently has a volume of distribution, close to
that of body water. It is primarily excreted in the urine as unchanged drug,
but a relatively small amount is excreted as the N-oxide metabolite.
Most of the severe clinical effects
following diethylcar-bamazine ingestion are due to allergic reactions to the
protein substance elaborated by the dying microfilariae and not to
diethylcarbamazine alone. The most disturbing adverse effect is the Mazotti reaction which is a result of
the host response to destruction of parasites, and is characterised by rash,
itching, tender lymphadenopathy, fever, arthralgia, and headache. It usually
occurs with the first dose and disappears in 3 to 7 days. Rare toxic effects
include encephalitis and retinal haemor-rhages (invariably during the course of
treatment of loiasis). Corneal opacities, anterior uveitis, visual field
restriction, optic atrophy, punctate keratitis, and chorioretinal changes have
been observed when diethylcarbamazine has been administered as eye drops (or
even orally) in onchocerciasis. Dose-related responses to diethylcarbamazine,
when used for therapy of filariasis, include weakness, dizziness, lethargy,
anorexia, and nausea. These effects generally occur within 1 to 2 hours
following a dose and may persist for several hours.
In a study of almost 300,000
therapeutic administrations of the drug, approximately 29% of the patients
experienced adverse reactions. The WHO no longer recommends the use of
diethylcarbamazine for onchocerciasis.
There is no antidote for
diethylcarbamazine poisoning.
Treatment is symptomatic and
supportive.
Niclosamide is a halogenated salicylanilide derivative which is mainly used in the treatment of tapeworm infestation. Unfortunately, while the drug may kill adult worms, ova are usually unaffected, which may result in cysticercosis due to liberation of viable ova into the lumen of the gut following digestion of dead worm segments. However, niclosamide is a very safe drug and is virtually free from serious side effects.
Piperazine is a cyclic secondary
amine which is very effective against roundworm, pinworm, and threadworm
infestations. It is also used as a corrosion inhibitor, insecticide, and
accelerator for curing polychloroprene.
Piperazine is given orally and acts
by inducing flaccid muscle paralysis in the worms facilitating their expulsion
by peristalsis. In therapeutic doses piperazine is safe, but overdose results
in convulsions, hallucinations, and respiratory failure. The problem is that
the margin between therapeutic and toxic dose is very narrow. Toxicity has been
reported to develop at doses as low as 30 mg/kg/day in patients with renal
failure, and 50 to 75 mg/kg/day in patients with normal renal function. Common
effects include nausea, vomiting, confusion, muscular weakness, and ataxia.
Treatment involves administration of anticonvulsants and symptomatic measures.
It is a pyrazinoisoquinoline
derivative and is effective against tapeworms, liver flukes, and
schistosomiasis. Praziquantel displays two major effects: it causes spastic paralysis
of worms, and (at higher doses) induces tegumental damage which acti-vates host
defence mechanisms resulting in the destruction of the worms.
Side effects include abdominal pain,
headache, drowsiness, vertigo, urticaria, rash, fever, and arthralgia. They
usually respond to symptomatic measures such as administration of analgesics.
Praziquantel is contraindicated in ocular cysticer-cosis since the host
response can cause irreversible damage to the eye. Concomitant intake of
alcohol can aggravate vertigo that is often associated with this drug.
It
is a depolarising neuromuscular blocking agent and causes spastic paralysis of
pinworm, roundworm, and hookworm. Adverse effects are mild and comprise
headache, drowsiness, insomnia, anorexia, nausea, abdominal cramps, diarrhoea,
rash, and occasional dizziness. Transient elevations of serum transaminase
levels have been reported in a small percentage of patients. It must not be
given along with piperazine because both are mutually antagonistic.
This drug is not in use in Western
countries because of the risk of agranulocytosis, but still finds a place in
India. Levamisole is effective against roundworms and hookworms. Apart from
blood dyscrasias, it can cause hepatic damage, GI distress, and olfactory
disturbances. Haematologic toxicity has included neutropenia, anaemia,
thrombocytopenia, and fatal cases of agranulocytosis have occurred with
therapy. Levamisole also has nicotinic and muscarinic effects at cholinergic
receptors. Initially there may be stimulation of the ganglionic and skeletal
muscle transmission, followed by blockade. CNS depression, clonic convulsions,
and dizziness may occur. An encephalop-athy-like syndrome has developed in some
patients during chronic therapy; onset of symptoms is variable. Taste
perver-sion, salivation, lip licking, and head shaking have occurred with
therapeutic doses. Frequent urination and defaecation have been reported.
Treatment is symptomatic and
supportive. Do not admin-ister antacids since levamisole may be better absorbed
in an alkaline medium. Atropine may help in some cases of levami-sole toxicity.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.